News

The CancerConnect News Feed is updated daily with the latest advances in cancer treatment including new drug developments, FDA approvals, advances in supportive care, and progress with new treatment strategies including, CAR-T, Immunotherapy, Precision Medicines, Molecular Testing, and pivotal clinical trial results. Need help? Connect with others, Ask an Expert at Cancer First Call, and/or receive the CancerConnect Newsletter.

August 25, 2025

New CAR T-Cell Therapy Shows Promise for Advanced Stomach and GEJ Cancer

Charles H. Weaver, MD
August 24, 2025

Precision Cancer Medicines for Colon Cancer

Charles H. Weaver, MD
August 22, 2025

New Approach May Help Lung Cancer Patients Resistant to Immunotherapy

Charles H. Weaver, MD
August 20, 2025

Omega-3s and Cancer: What You Need to Know

Charles H. Weaver, MD
August 20, 2025

FDA Grants Accelerated Approval to Zongertinib (Hernexeos) for Non-Squamous NSCLC with HER2 TKD Mutations

Charles H. Weaver, MD
August 20, 2025

FDA Grants Accelerated Approval to Dordaviprone (Modeyso) for Diffuse Midline Glioma with H3 K27M Mutation

Charles H. Weaver, MD
August 19, 2025

Managing Breast Cancer Radiation-induced Dermatitis

Charles H. Weaver, MD
July 25, 2025

SurvaxM May Prolong Survival in Glioblastoma

Charles H. Weaver, MD
July 22, 2025

Can The Microbiome Influence Treatment Outcomes in Cancer Patients?

Charles H. Weaver, MD
July 22, 2025

Dual-Target CAR T-Cell Therapy Offers New Hope for Aggressive Brain Cancer

Charles H. Weaver, MD
July 22, 2025

Groundbreaking Cell Therapy Shows Dramatic Early Results in Glioblastoma Patients

Charles H. Weaver, MD
June 4, 2025

FDA Approves Darolutamide (Nubeqa) for Metastatic Castration-Sensitive Prostate Cancer

Charles H. Weaver, MD